Trulieve Is Still Not A Good Cannabis Stock

Trulieve reported Q1 results, beating revenue and adjusted EBITDA estimates with 4% sequential revenue growth and a 21% increase in adjusted EBITDA. Analysts have revised their outlook for Trulieve, …

Author: CSN